Related Experiment Video
Updated: Sep 27, 2025
09:16
Highly Sensitive Measurement of Glomerular Permeability in Mice with Fluorescein Isothiocyanate-polysucrose 70
Published on: August 9, 2019
7.0K
Empagliflozin Changes Urine Supersaturation by Decreasing pH and Increasing Citrate
Dusan Harmacek1, Menno Pruijm1, Michel Burnier2
1Department of Biomedical Sciences, University of Lausanne, Lausanne, Switzerland.
Journal of the American Society of Nephrology : JASN
|April 7, 2022
Summary
This study investigated how empagliflozin affects kidney oxygen levels in healthy individuals. Results showed empagliflozin influences renal oxygenation, offering insights into its kidney-related effects.
Area of Science:
- Pharmacology
- Nephrology
- Cardiovascular Research
Background:
- The study investigated the effects of empagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, on renal oxygenation in healthy volunteers.
- The trial, registered as NCT03093103 (EMPA-REIN), aimed to understand the drug's impact on kidney blood flow and oxygen levels.
Discussion:
- Empagliflozin demonstrated an influence on renal oxygenation parameters.
- Understanding these hemodynamic changes is crucial for elucidating the mechanisms behind SGLT2 inhibitors' renal benefits.
Key Insights:
- Empagliflozin alters renal oxygenation in healthy individuals.
- This finding contributes to the understanding of SGLT2 inhibitors' physiological effects beyond glucose lowering.
Outlook:
- Further research could explore these effects in patient populations with kidney disease.
- Investigating the long-term implications of empagliflozin-induced renal oxygenation changes is warranted.
Related Concept Videos
01:23Dipeptidyl Peptidase 4 Inhibitors
274
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
274
01:20Formation of Dilute Urine
1.9K
The formation of dilute urine is a critical renal adaptation that maintains fluid balance, particularly during periods of high fluid intake. This process primarily involves the juxtamedullary nephrons. By adjusting the permeability of water and ions in response to physiological conditions, the kidneys can either conserve or excrete water, resulting in concentrated or dilute urine.
Filtrate Osmolarity in the PCT
Initially, as the filtrate passes through the proximal convoluted tubule (PCT), its...
Filtrate Osmolarity in the PCT
Initially, as the filtrate passes through the proximal convoluted tubule (PCT), its...
1.9K
01:22Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
311
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
311
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
828
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
828
01:06Oral Hypoglycemic Agents: Glinides
283
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
283
01:24Glucagon-like Receptor Agonists
451
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
451